GSA Capital Partners’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
KBG
PMG
GSA Capital Partners's OGN Position: Q1 2026 in Review
GSA Capital Partners sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 54,545 shares — an estimated $391K sold.
GSA Capital Partners first reported a position in OGN in Q3 2022 and held it in 6 quarters. The position peaked at $1.83M in Q2 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- GSA Capital Partners reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
- GSA Capital Partners sold 54,545 Organon & Co shares in Q1 2026, an estimated $391K.
- GSA Capital Partners first reported a position in Organon & Co in Q3 2022 and held it in 6 quarters.
- GSA Capital Partners's Organon & Co position peaked at $1.83M in Q2 2025.
- 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.